248 related articles for article (PubMed ID: 32525153)
1. Transition metal chelators, pro-chelators, and ionophores as small molecule cancer chemotherapeutic agents.
Steinbrueck A; Sedgwick AC; Brewster JT; Yan KC; Shang Y; Knoll DM; Vargas-Zúñiga GI; He XP; Tian H; Sessler JL
Chem Soc Rev; 2020 Jun; 49(12):3726-3747. PubMed ID: 32525153
[TBL] [Abstract][Full Text] [Related]
2. Plant-derived chelators and ionophores as potential therapeutics for metabolic diseases.
Lee VJ; Janisse SE; Heffern MC
Chem Soc Rev; 2023 Jun; 52(11):3927-3945. PubMed ID: 37203389
[TBL] [Abstract][Full Text] [Related]
3. Developing drugs targeting transition metal homeostasis.
Weekley CM; He C
Curr Opin Chem Biol; 2017 Apr; 37():26-32. PubMed ID: 28040658
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Metal Homeostasis for Cancer Therapy.
Yang Y; Fan H; Guo Z
Chempluschem; 2024 Jun; 89(6):e202300624. PubMed ID: 38315756
[TBL] [Abstract][Full Text] [Related]
5. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
6. Novel chelators for cancer treatment: where are we now?
Merlot AM; Kalinowski DS; Richardson DR
Antioxid Redox Signal; 2013 Mar; 18(8):973-1006. PubMed ID: 22424293
[TBL] [Abstract][Full Text] [Related]
7. Copper and Copper Complexes in Tumor Therapy.
Wang Y; Tang T; Yuan Y; Li N; Wang X; Guan J
ChemMedChem; 2024 Jun; 19(11):e202400060. PubMed ID: 38443744
[TBL] [Abstract][Full Text] [Related]
8. Metal Complexes or Chelators with ROS Regulation Capacity: Promising Candidates for Cancer Treatment.
Li X; Wang Y; Li M; Wang H; Dong X
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011380
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: In vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action.
Khan S; Malla AM; Zafar A; Naseem I
PLoS One; 2017; 12(8):e0181783. PubMed ID: 28763458
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the cytotoxic implications of metal chelators against melanoma and approaches to improve the cytotoxicity profiles of metal coordinating agents.
Akladios FN; Andrew SD; Parkinson CJ
Biometals; 2016 Oct; 29(5):789-805. PubMed ID: 27389037
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Insights of Chelator Complexes with Essential Transition Metals: Antioxidant/Pro-Oxidant Activity and Applications in Medicine.
Timoshnikov VA; Selyutina OY; Polyakov NE; Didichenko V; Kontoghiorghes GJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163169
[TBL] [Abstract][Full Text] [Related]
12. Unveiling the Potential of Transition Metal Complexes for Medicine: Translational in Situ Activation of Metal-Based Drugs from Bench to in Vivo Applications.
Silva MJSA; Gois PMP; Gasser G
Chembiochem; 2021 May; 22(10):1740-1742. PubMed ID: 33507625
[TBL] [Abstract][Full Text] [Related]
13. Targeting copper in cancer therapy: 'Copper That Cancer'.
Denoyer D; Masaldan S; La Fontaine S; Cater MA
Metallomics; 2015 Nov; 7(11):1459-76. PubMed ID: 26313539
[TBL] [Abstract][Full Text] [Related]
14. Recent development of transition metal complexes with in vivo antitumor activity.
Liang JX; Zhong HJ; Yang G; Vellaisamy K; Ma DL; Leung CH
J Inorg Biochem; 2017 Dec; 177():276-286. PubMed ID: 28641893
[TBL] [Abstract][Full Text] [Related]
15. Advances on Chelation and Chelator Metal Complexes in Medicine.
Kontoghiorghes GJ
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260293
[TBL] [Abstract][Full Text] [Related]
16. Metal ionophores - an emerging class of anticancer drugs.
Ding WQ; Lind SE
IUBMB Life; 2009 Nov; 61(11):1013-8. PubMed ID: 19859983
[TBL] [Abstract][Full Text] [Related]
17. Polyether ionophores-promising bioactive molecules for cancer therapy.
Huczyński A
Bioorg Med Chem Lett; 2012 Dec; 22(23):7002-10. PubMed ID: 23063400
[TBL] [Abstract][Full Text] [Related]
18. Structural basis, chemical driving forces and biological implications of flavones as Cu(II) ionophores.
Dai F; Yan WJ; Du YT; Bao XZ; Li XZ; Zhou B
Free Radic Biol Med; 2017 Jul; 108():554-563. PubMed ID: 28431962
[TBL] [Abstract][Full Text] [Related]
19. Glycosylated copper(II) ionophores as prodrugs for β-glucosidase activation in targeted cancer therapy.
Oliveri V; Viale M; Caron G; Aiello C; Gangemi R; Vecchio G
Dalton Trans; 2013 Feb; 42(6):2023-34. PubMed ID: 23174818
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of transition-metal steroid derivatives.
Le Bideau F; Dagorne S
Chem Rev; 2013 Oct; 113(10):7793-850. PubMed ID: 23931623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
